A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders

Camlin, Thaddeus James, Eulert, Donald, Horvath, Arthur Thomas, Bucky, Steven F., Barsuglia, Joseph P., Polanco, Martin · 2018 · Journal of Psychedelic Studies

AI-extracted · unverified · confirm at source

10 opioid-dependent participants reported ibogaine attenuated withdrawal (100%), eliminated cravings (100%), increased self-acceptance (100%), and induced spiritual outlook (70%)

Dosing: 15–20 mg/kg therapeutic dose referenced; LD50 264 mg/kg (oral)

Sample size: 10

Contraindications: Preexisting medical conditions, Opioid use within 72 hours of ibogaine ingestion